...
首页> 外文期刊>Cellular and molecular life sciences: CMLS >We find them here, we find them there: Functional bacterial amyloid
【24h】

We find them here, we find them there: Functional bacterial amyloid

机译:我们在这里找到它们,我们在那里找到它们:功能性细菌淀粉样蛋白

获取原文
获取原文并翻译 | 示例

摘要

Protein amyloid is often deposited in connection with neurodegenerative diseases. Such deposits generally possess three principal drawbacks: cytotoxicity, lack of spatial control in their deposition and structural polymorphism. These are typical features of biologically non-optimized systems which have not been exposed to evolutionary pressure. Nevertheless, Nature uses the cross-beta self-organizing principle in many structural contexts where a strong but pliable material is needed. Functional amyloid is found in humans, invertebrates, fungi and, not least, bacteria, in which amyloid may be the rule rather than the exception. Detailed case studies reveal how directed nucleation can use tailor-made proteins optimized to assume a specific amyloid conformation, leading to remarkably robust assemblies. This makes it highly challenging to purify and analyze the products formed in vivo. We contrast pathogenic and in-vitro-formed amyloid with functional amyloid, paying particular reference to bacterial amyloid, and discuss challenges and perspectives in identifying and characterizing this class of protein.
机译:蛋白质淀粉样蛋白通常与神经退行性疾病有关沉积。这种沉积物通常具有三个主要缺点:细胞毒性,沉积物缺乏空间控制和结构多态性。这些是未受到进化压力的非生物学优化系统的典型特征。尽管如此,在许多需要坚固但柔韧的材料的结构环境中,自然界还是使用交叉beta自组织原理。功能性淀粉样蛋白存在于人类,无脊椎动物,真菌以及细菌中,其中淀粉样蛋白可能是规则而非例外。详细的案例研究揭示了定向成核如何使用经过优化的量身定制的蛋白质来呈现特定的淀粉样蛋白构象,从而产生了非常坚固的装配体。这使得纯化和分析体内形成的产物极具挑战性。我们将致病性和体外形成的淀粉样蛋白与功能性淀粉样蛋白进行对比,特别提及细菌淀粉样蛋白,并讨论鉴定和表征此类蛋白的挑战和观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号